These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 626182)

  • 1. Evidence for reinstatement of infants 12 to 14 months of age into routine measles immunization programs.
    Wilkins J; Wehrle PF
    Am J Dis Child; 1978 Feb; 132(2):164-6. PubMed ID: 626182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Additional evidence against measles vaccine administration to infants less than 12 months of age: altered immune response following active/passive immunization.
    Wilkins J; Wehrle PF
    J Pediatr; 1979 Jun; 94(6):865-9. PubMed ID: 448525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decay of maternally derived measles antibody in a highly vaccinated population in southern Israel.
    Dagan R; Slater PE; Duvdevani P; Golubev N; Mendelson E
    Pediatr Infect Dis J; 1995 Nov; 14(11):965-9. PubMed ID: 8584363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of maternally derived antibody on the efficacy of further attenuated measles vaccine.
    Stewien KE; Barbosa V; de Lima OS; Osiro K
    Infection; 1978; 6(5):207-10. PubMed ID: 730390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age for measles immunization seroconversion after measles vaccination at 6-8 months of age--a randomized controlled trial.
    Deivanayagam N; Ramamurthy N; Krishnamurthy PV; Shankar VJ; Ashok TP; Nedunchelian K; Mala N; Ahmed SS
    Indian Pediatr; 1990 Nov; 27(11):1171-6. PubMed ID: 2081639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measles vaccine immunogenicity in 6- versus 15-month-old infants born to mothers in the measles vaccine era.
    Johnson CE; Nalin DR; Chui LW; Whitwell J; Marusyk RG; Kumar ML
    Pediatrics; 1994 Jun; 93(6 Pt 1):939-44. PubMed ID: 8190581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced seroconversion to measles in infants given vitamin A with measles vaccination.
    Semba RD; Munasir Z; Beeler J; Akib A; Muhilal ; Audet S; Sommer A
    Lancet; 1995 May; 345(8961):1330-2. PubMed ID: 7752754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deficiency of the humoral immune response to measles vaccine in infants immunized at age 6 months.
    Gans HA; Arvin AM; Galinus J; Logan L; DeHovitz R; Maldonado Y
    JAMA; 1998 Aug; 280(6):527-32. PubMed ID: 9707142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunisation of 4-6 month old Gambian infants with Edmonston-Zagreb measles vaccine.
    Whittle HC; Rowland MG; Mann GF; Lamb WH; Lewis RA
    Lancet; 1984 Oct; 2(8407):834-7. PubMed ID: 6148572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune response to measles, mumps & rubella vaccine at 9, 12 & 15 months of age.
    Singh R; John TJ; Cherian T; Raghupathy P
    Indian J Med Res; 1994 Oct; 100():155-9. PubMed ID: 7851964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimum age for measles immunization in Romania.
    Biberi-Moroeanu S; Tiţeica-Boldeanu M; Munţiu A; Petrenco M; Suter C
    Virologie; 1986; 37(1):3-8. PubMed ID: 3962178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response to measles vaccine in Haitian infants 6 to 12 months old. Influence of maternal antibodies, malnutrition, and concurrent illnesses.
    Halsey NA; Boulos R; Mode F; Andre J; Bowman L; Yaeger RG; Toureau S; Rohde J; Boulos C
    N Engl J Med; 1985 Aug; 313(9):544-9. PubMed ID: 4022091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early two-dose measles vaccination schedule in Guinea-Bissau: good protection and coverage in infancy.
    Garly ML; Martins CL; Balé C; da Costa F; Dias F; Whittle H; Aaby P
    Int J Epidemiol; 1999 Apr; 28(2):347-52. PubMed ID: 10342702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determining infants' age for measles vaccination based on persistence of protective level of maternal measles antibody.
    Shilpi T; Sattar H; Miah MR
    Bangladesh Med Res Counc Bull; 2009 Dec; 35(3):101-4. PubMed ID: 20922913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of revaccinating children who initially received measles vaccine before 10 months of age.
    Stetler HC; Orenstein WA; Bernier RH; Herrmann KL; Sirotkin B; Hopfensperger D; Schuh R; Albrecht P; Lievens AW; Brunell PA
    Pediatrics; 1986 Apr; 77(4):471-6. PubMed ID: 3960615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MEASLES IMMUNIZATION INCORPORATED IN THE ROUTINE SCHEDULE FOR INFANTS: EFFICACY OF A COMBINED INACTIVATED-LIVE VACCINATION REGIMEN.
    KRUGMAN S; STONE S; HU R; FRIEDMAN H
    Pediatrics; 1964 Dec; 34():795-7. PubMed ID: 14243467
    [No Abstract]   [Full Text] [Related]  

  • 17. Transplacental immunity and waning of maternal antibody in measles.
    Sood DK; Kumar S; Singh S; Sharma SB; Sokhey J; Singh H
    Indian J Pediatr; 1995; 62(1):95-9. PubMed ID: 10829850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of AIK-C measles vaccine in infants at 6 months with Schwarz vaccine at 9 months: a randomized controlled trial in Ghana.
    Nkrumah FK; Osei-Kwasi M; Dunyo SK; Koram KA; Afari EA
    Bull World Health Organ; 1998; 76(4):353-9. PubMed ID: 9803586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistence of maternal antibody in infants beyond 12 months: mechanism of measles vaccine failure.
    Albrecht P; Ennis FA; Saltzman EJ; Krugman S
    J Pediatr; 1977 Nov; 91(5):715-8. PubMed ID: 909009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protecting infants against measles in England and Wales: a review.
    Manikkavasagan G; Ramsay M
    Arch Dis Child; 2009 Sep; 94(9):681-5. PubMed ID: 19457878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.